SciELO - Scientific Electronic Library Online

 
vol.69 issue1Cystic craniopharyngioma: intratumoral chemotherapy with alpha interferonNeuropathic pain characteristics in patients from Curitiba (Brazil) with spinal cord injury author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Arquivos de Neuro-Psiquiatria

Print version ISSN 0004-282X

Abstract

PIOVESAN, Elcio Juliato et al. Botulinum toxin type-A effect as a preemptive treatment in a model of acute trigeminal pain: a pre-clinical double-blind and placebo-controlled study. Arq. Neuro-Psiquiatr. [online]. 2011, vol.69, n.1, pp. 56-63. ISSN 0004-282X.  http://dx.doi.org/10.1590/S0004-282X2011000100012.

The purpose of this study was to investigate if botulinum neurotoxin type-A (BoNT/A) had a preemptive antinociceptive effect in a formalin-induced orofacial pain model (FT). To test this hypothesis, male Rattus norvegicus were injected with isotonic saline solution 0.9% or BoNT/A administered as a 40 μl bolus, lateral to their nose, at 24 hours, 8, 15, 22, 29 or 36 days pre-FT. The procedures were repeated 42 days later. Influence on motor activity was assessed through the open-field test. Pain scores corresponded to the time spent rubbing and flicking the injected area. Animals pre-treated with BoNT/A at the first protocol (8 days subgroup) showed reduced inflammatory scores (p=0.011). For the other groups no significant results were observed at any phase. Motor activity was similar in both groups. BoNT/A showed to be effective preventing inflammatory pain up to eight days after the first treatment, an effect not reproduced on the second dose administration.

Keywords : antinociceptive effect; orofacial pain; preemptive treatment; botulinum neurotoxin type-A.

        · abstract in Portuguese     · text in English     · pdf in English